What is PMV Pharmaceuticals, Inc's Market Cap?

PMV Pharmaceuticals, Inc's Market Cap is $73.2M, based on as-reported figures from SEC (XBRL) filings.

What is PMV Pharmaceuticals, Inc's Enterprise Value?

PMV Pharmaceuticals, Inc's Enterprise Value is -$6.2M, based on as-reported figures from SEC (XBRL) filings.

What is PMV Pharmaceuticals, Inc's EV / EBITDA?

PMV Pharmaceuticals, Inc's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.

What is PMV Pharmaceuticals, Inc's Net Income (TTM)?

PMV Pharmaceuticals, Inc's Net Income (TTM) is -$75.2M, based on as-reported figures from SEC (XBRL) filings.

What is PMV Pharmaceuticals, Inc's EBITDA?

PMV Pharmaceuticals, Inc's EBITDA is -$79.5M, based on as-reported figures from SEC (XBRL) filings.

What is PMV Pharmaceuticals, Inc's Diluted EPS (TTM)?

PMV Pharmaceuticals, Inc's Diluted EPS (TTM) is -1.41, based on as-reported figures from SEC (XBRL) filings.

What is PMV Pharmaceuticals, Inc's Net Debt?

PMV Pharmaceuticals, Inc's Net Debt is -$79.4M, based on as-reported figures from SEC (XBRL) filings.

PMV Pharmaceuticals, Inc (PMVP) Financial Statements

PMV Pharmaceuticals, Inc

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG007NM4862

XNAS · usd

1.37▲ 0.03 (2.24%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close1.34

Day's Range1.29 – 1.38

52-Week Range1.02 – 1.88

Volume1.2M

Avg Volume570.2K

Share Statistics

Shares Outstanding

Employees54

ExchangeXNAS

Listed2020-09-25

Share count as of August 14, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about PMV Pharmaceuticals, Inc (PMVP)

What is PMV Pharmaceuticals, Inc's Market Cap?: PMV Pharmaceuticals, Inc's Market Cap is $73.2M, based on as-reported figures from SEC (XBRL) filings.
What is PMV Pharmaceuticals, Inc's Enterprise Value?: PMV Pharmaceuticals, Inc's Enterprise Value is -$6.2M, based on as-reported figures from SEC (XBRL) filings.
What is PMV Pharmaceuticals, Inc's EV / EBITDA?: PMV Pharmaceuticals, Inc's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is PMV Pharmaceuticals, Inc's Net Income (TTM)?: PMV Pharmaceuticals, Inc's Net Income (TTM) is -$75.2M, based on as-reported figures from SEC (XBRL) filings.
What is PMV Pharmaceuticals, Inc's EBITDA?: PMV Pharmaceuticals, Inc's EBITDA is -$79.5M, based on as-reported figures from SEC (XBRL) filings.
What is PMV Pharmaceuticals, Inc's Diluted EPS (TTM)?: PMV Pharmaceuticals, Inc's Diluted EPS (TTM) is -1.41, based on as-reported figures from SEC (XBRL) filings.
What is PMV Pharmaceuticals, Inc's Net Debt?: PMV Pharmaceuticals, Inc's Net Debt is -$79.4M, based on as-reported figures from SEC (XBRL) filings.